All Regulation articles
-
OpinionPolicies for advanced wound care dressings in India
India faces a growing crisis in wound treatment, driven by diabetes and an ageing population. A new policy approach could enable Indian innovation to meet this need.
-
BusinessExplainer: Why is the US eliminating synthetic food dyes?
What’s the evidence for harm, and how does the US approach compare internationally
-
OpinionModerna’s vaccine regulatory hokey-cokey
US FDA initially refused to accept flu vaccine for review, but has since reversed that decision
-
BusinessEU adds hefty anti-dumping duties to 1,4-butanediol
Imports from China, US and Saudi Arabia will see tariffs of 52–143%
-
NewsEPA moves to eliminate basis of greenhouse gas regulations
Legal challenges predicted as US environmental protection agency rescinds long-standing ‘endangerment finding’
-
OpinionSlimming down competition over weight-loss drugs
Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention
-
BusinessControversial weedkiller dicamba reapproved in the US
Regulator says new label restrictions will prevent damage of nearby crops
-
OpinionProbing PFAS policies in the UK and EU
The UK has set out its approach to regulating fluorochemicals, and the EU has projected the savings from a proposed ban
-
NewsUK government sets out plan to tackle PFAS threat
Report accepts that regulation is needed, but warns transition away from PFAS will take time
-
NewsCongress rescues industry watchdog earmarked for closure by Trump administration
Agency has received level funding of $14 million to continue to investigate and report back on US chemical accidents
-
OpinionCarbon border taxes may do more harm than good
Industry argues UK proposals are flawed and will not promote decarbonisation
-
OpinionTrump’s attack on science is shaking industry’s foundations
By dismantling scientific enterprise, the US risks ‘taking a hammer to our miracle machine’
-
OpinionPlastic recycling’s perfect storm
Pending policies that demand more recycling cannot offset problems of high costs and competition from cheap virgin polymers
-
NewsEPA delivers mixed finding on carcinogenic rubber ingredient
US environmental agency says 1,3-butadiene is harmful for some industry workers, but not for the environment or those living near plants using it
-
BusinessPlastic recycling is contracting when it needs to grow
High costs, oversupply of virgin polymers and complex political environment are challenging industry
-
-
BusinessChemicals industry roundup 2025
Europe hit hard by China’s independence push, but India is growing
-
OpinionA unifying force for African medicines
The new African Medicines Agency is hugely important but faces significant challenges
-
BusinessUS backs Bayer–Monsanto with glyphosate decision
Solicitor general says federal rules override state laws on cancer warnings
-
BusinessUK agrees higher drug prices to secure zero-tariff deal with US
NHS could pay up to 25% more for innovative drugs, but exports will be tariff free for three years